Analysts showing optimistic trends for Deckers Outdoor Corporation(NYSE:DECK) : Progenics Pharmaceuticals Inc.(NASDAQ:PGNX)

0
4

Deckers Outdoor Corporation (DECK) will report its next earnings on May 21 AMC. The company reported the earnings of $0.57/Share in the last quarter where the estimated EPS by analysts was $0.09/share. The difference between the expected and actual EPS was $0.48/share, which represents an Earnings surprise of 533.3%.

Many analysts are providing their Estimated Earnings analysis for Deckers Outdoor Corporation and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $-1.17/share. These analysts have also projected a Low Estimate of $-1.6/share and a High Estimate of $-0.94/share.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for Deckers Outdoor Corporation as 251.57 Million. According to these analysts, the Low Revenue Estimate for Deckers Outdoor Corporation is 202.45 Million and the High Revenue Estimate is 270 Million. The company had Year Ago Sales of 259.71 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for DECK to be -76.1%. They are projecting Next Quarter growth of -23.62%. For the next 5 years, Deckers Outdoor Corporation is expecting Growth of 30.3% per annum, whereas in the past 5 years the growth was -18.09% per annum.

Some buy side analysts are also providing their Analysis on Deckers Outdoor Corporation, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.58 and Average Volume (3 months) is 521.27 million. The company’s P/E (price to earnings) ratio is 20.08 and Forward P/E ratio of 18.93.

The company shows its Return on Assets (ROA) value of 16.5%. The Return on Equity (ROE) value stands at 27.3%. While it’s Return on Investment (ROI) value is 24.9%.

While looking at the Stock’s Performance, Deckers Outdoor Corporation currently shows a Weekly Performance of 9.25%, where Monthly Performance is 31.63%, Quarterly performance is 9.43%, 6 Months performance is 15.96% and yearly performance percentage is 28.74%. Year to Date performance value (YTD perf) value is 15.97%. The Stock currently has a Weekly Volatility of 5.79% and Monthly Volatility of 5.47%.

Progenics Pharmaceuticals Inc. (PGNX) will report its next earnings on May 07 BMO. The company reported the earnings of $-0.19/Share in the last quarter where the estimated EPS by analysts was $-0.22/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 13.6%.

Many analysts are providing their Estimated Earnings analysis for Progenics Pharmaceuticals Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.24/share. These analysts have also projected a Low Estimate of $-0.24/share and a High Estimate of $-0.24/share.

In case of Revenue Estimates, 1 analysts have provided their consensus Average Revenue Estimates for Progenics Pharmaceuticals Inc. as 8.2 Million. According to these analysts, the Low Revenue Estimate for Progenics Pharmaceuticals Inc. is 8.2 Million and the High Revenue Estimate is 8.2 Million. The company had Year Ago Sales of 9.97 Million.

Some buy side analysts are also providing their Analysis on Progenics Pharmaceuticals Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.73 and Average Volume (3 months) is 892.33 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -53.2%. The Return on Equity (ROE) value stands at -129.5%. While it’s Return on Investment (ROI) value is -77.3%.

While looking at the Stock’s Performance, Progenics Pharmaceuticals Inc. currently shows a Weekly Performance of 7.07%, where Monthly Performance is 7.61%, Quarterly performance is -11.11%, 6 Months performance is -19.85% and yearly performance percentage is 1.19%. Year to Date performance value (YTD perf) value is -16.7%. The Stock currently has a Weekly Volatility of 7.63% and Monthly Volatility of 6.78%.

SHARE